Home

research

Lead the field

Work with precision at unrivaled speed to make informed decisions backed up by science. To meet the challenges of modern drug discovery, take advantage of BioSolveIT’s detailed and precise results — without compromise. We will address every step of your needs, from start to finish.
partners

Discover with confidence

Profit from our long-standing experience and collaboration history with Fortune 100 pharma companies and academia. Our secure software has been developed and backed by renowned partners - including BAYER, Roche, Merck, BASF, and others. BioSolveIT’s success record is cited in thousands of publications worldwide.
start right away

Start right away

BioSolveIT’s technology is fine-tuned for the needs of the pharma industry, academics, beginners, and veterans alike. Clean and compherensive user interface removes the need for a learning curve. Easy access fostered by intuitive operation will maximize the likelihood of your success. Simply download the multiplatform software and discover active molecules!
drug discovery evolution

Experience drug discovery

Evolve the way you approach drug design, with the most liberating breakthrough. The stimulating interface creates a dialog between you and your compound where you can see why something is considered good or bad. Clean visualization combined with scientific finesse mold into a fun-to-use drug design experience.

Current news

category
Webinars
Exploring the Untargeted Cysteinome of Protein Kinases
Thu, 09 Dec 2021, 16:30 CET (Berlin)
Protein kinases are now among the major drug targets with over 65 inhibitors approved since the groundbreaking approval of imatinib (Gleevec) in 2001. Covalent targeting approaches, which have gained traction in recent years, have proven particularly useful in the protein kinase field. Typically, covalent inhibitors feature superior potency and efficacy...
Read on
category
Webinars
The Exciting Story of Covalent Reversible Inhibition of Rhodesain, a Key Player in African Sleeping Sickness
Tue, 16 Nov 2021, 15:00
Human African Trypanosomiasis (HAT, African Sleeping Sickness) is a fatal, neglected tropical disease caused by the parasites Trypanosoma brucei. Most available drugs for treatment of the disease lack efficiency and have severe side effects. α-halovinylsulfones as covalent reversible inhibitors of the parasitic cysteine protease “rhodesain” have proven to be promising...
Read on
category
Software
Double Release — SeeSAR 11.1 and infiniSee 3.2
October 14, 2021 12:19
The BioSolveIT October updates are here and this time we are proud to announce a simultanious double release of both our platforms SeeSAR and infiniSee. SeeSAR 11.1 SeeSAR Hephaestus received a powerful update to support users in their drug discovery efforts. The covalent complex assessment received a visual update where...
Read on